about
Autoimmune T-cell reactivity to myelin proteolipids and glycolipids in multiple sclerosisImmune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?The role of epigenetic mechanisms and processes in autoimmune disordersReactivity to Novel Autoantigens in Patients with Coexisting Central Nervous System Demyelinating Disease and Autoimmune Thyroid DiseaseThe effect of ageing on human lymphocyte subsets: comparison of males and femalesGene expression in the spinal cord in female lewis rats with experimental autoimmune encephalomyelitis induced with myelin basic proteinThe presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DRbeta1 chain is associated with the clinical course of multiple sclerosisMyelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis.Sexual dimorphism in autoimmune disease.Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms.The Role of HLA in MS Susceptibility and Phenotype.Taming the TCR: antigen-specific immunotherapeutic agents for autoimmune diseases.An investigation of the C77G and C772T variations within the human protein tyrosine phosphatase receptor type C gene for association with multiple sclerosis in an Australian population.Novel Therapeutics for Multiple Sclerosis Designed by Parasitic Worms.Quantitative proteome profiling of CNS-infiltrating autoreactive CD4+ cells reveals selective changes during experimental autoimmune encephalomyelitis.Correlation of adrenomedullin gene expression in peripheral blood leukocytes with severity of ischemic stroke.Prominent brainstem and cerebellar involvement in multiple sclerosis with psoriasis.CTLA-4 single-nucleotide polymorphisms in a Caucasian population with schizophrenia.Orientation of myelin proteolipid protein in the oligodendrocyte cell membrane.Predicting the effects of potentially therapeutic modified peptides on polyclonal T cell populations in a mouse model of multiple sclerosis.Elevated levels of autoantibodies targeting the M1 muscarinic acetylcholine receptor and neurofilament medium in sera from subgroups of patients with schizophrenia.Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain-Barré syndrome.Studies of HLA associations in male and female patients with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).Study of leukemia inhibitory factor polymorphism within an Australian multiple sclerosis population.Circulating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: Effect on outcome.Investigation of the [-/A]8 and C1236T genetic variations within the human Toll-like receptor 3 gene for association with multiple sclerosis.PLP1 Mutations in Patients with Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the MutationsEarly pregnancy factor suppresses experimental autoimmune encephalomyelitis induced in Lewis rats with myelin basic protein and in SJL/J mice with myelin proteolipid protein peptide 139-151Characterization of a new rat model for chronic inflammatory demyelinating polyneuropathiesIncreased constitutive activation of NF-κB p65 (RelA) in peripheral blood cells of patients with progressive multiple sclerosisThiopalmitoylation of Altered Peptide Ligands Enhances Their Protective Effects in an Animal Model of Multiple SclerosisLevels of phosphorylated axonal neurofilament subunit H (pNfH) are increased in acute ischemic strokeIncreased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosisGenetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S miceImmunogenic and encephalitogenic epitope clusters of myelin proteolipid proteinAn altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitisA single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoireDistinctive molecular markers and biological activities in two tumour-specific murine T suppressor factorsEffects of anti-idiotype vaccine on tumour growth and on production of soluble factors modulating cell-mediated immunity in vitro
P50
Q27012075-2DEC1775-2C65-4BB0-A951-FA124B0B5BA6Q28303348-85355DC2-E23C-4524-B8E1-188876A0831BQ28389137-A6DE8CD5-E808-49E1-B3F9-AB91EEA56591Q33645752-C06D451D-0690-4179-9271-CCF9FEF20F47Q33804295-63241B80-08F2-4936-BD46-FE13AAA893D5Q34472020-DE09DC40-7010-4A14-BB12-D9A02CC4DEC3Q35487679-E7D64AC3-F3DA-45CC-A0D7-0367F71375D7Q37172971-7524930F-22D0-424A-98CC-64C396A14C2BQ37435137-AF40E161-E185-473C-88AC-660057343B4AQ37595548-F69761E3-B3FB-4814-9CAE-76067038D82BQ37862835-73117661-AFBD-40CC-9074-611A7D5AB575Q38287223-84F1359D-C50C-43CA-B1D9-AA1E82D78C01Q38477340-82C8A677-867E-4783-9DE3-7191BEA3DD68Q45036480-142472A4-52F7-4B41-99F2-0942343EDB7CQ45842759-85EF14C5-18D6-48F4-B281-62610EB8B093Q45845904-9200065E-DDFC-4A05-A477-E61DDA182333Q46056898-03550BB4-3F9E-4ACF-B40F-82B21ECE3B61Q47687532-A5238F52-3462-490C-A30C-E3751D9A559BQ48886486-F36D8961-3FF0-48BC-BAA9-C2F20BD5EB7AQ49032270-00E6D1C1-157B-4BAD-AAFC-0E5EA80E7E27Q50644184-2FA9EA07-214F-46F8-A113-7B2809F219BEQ50654275-B54438E2-FA98-40FF-A0AB-EAAF23504A9DQ50766428-6F035DC9-597F-4810-99F4-483904C261C3Q51789015-D2FA76B7-F06A-4AFD-95AF-F27879085995Q51793107-D3CCBEA5-C845-4D3B-A109-447C816EE187Q52150778-8A1C60BE-5054-4A9D-96C5-D5158C671710Q53118085-CAA2724B-2139-4E4E-B5FE-546ABFF68F34Q57476157-8157D2F3-9069-4802-AFC2-E701A9C41EB8Q57693313-2A87594A-73B7-4758-AFD3-7BDC9EFBCFD9Q60731232-BA971D42-C408-4839-B321-280EC2E4F710Q63535124-9CEAA385-2416-453F-B3F3-5FC47D26C22AQ63535217-1E7DC3B0-F271-4872-B5B2-67CB9B7EF02AQ63535271-C1873A19-60F4-4D22-BD52-67118C51A473Q63535310-E1B6F23A-2BF5-4D2D-890D-D6BECE1295BEQ63535312-17722D1A-9E8E-49BA-A59A-A47C9C8095FBQ63535313-CC096984-E406-4AF6-8905-DA8A3712240DQ63535314-9B6D21BB-CB93-4AFD-8D6E-0670A573632FQ63535316-72A21CD6-0B6C-4508-AA7C-45695B866E05Q63535320-3784A613-2B7F-4790-9674-A490A320DE83Q63535321-27EBFD42-B7B4-4D7B-ADD5-7A558332A560
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Judith M Greer
@ast
Judith M Greer
@en
Judith M Greer
@es
Judith M Greer
@nl
Judith M Greer
@sl
type
label
Judith M Greer
@ast
Judith M Greer
@en
Judith M Greer
@es
Judith M Greer
@nl
Judith M Greer
@sl
prefLabel
Judith M Greer
@ast
Judith M Greer
@en
Judith M Greer
@es
Judith M Greer
@nl
Judith M Greer
@sl
P1053
C-4945-2009
P106
P21
P2798
P31
P3829
P496
0000-0003-4440-4309
P569
2000-01-01T00:00:00Z